An Exclusive Interview with Dr Jan-Anders Karlsson - CEO of S*BIO

摘要

Can we have an insight into the background and history of S*BIO? Why did Chiron (a large pharma company) choose Singapore as its base? Established in 2000 as a joint venture between the Singapore Economic Development Board Investments and Chiron Corporation, S*BIO is Singapore's first fully integrated drug discovery company. With a focus on cancer therapeutics we are consolidating our position as one of the leaders of Singapore's biotechnology industry.